Effect of cholinergic and anticholinergic agents on tardive dyskinesia. 1974

H L Klawans, and R Rubovits

Tardive dyskinesia, like several other choreiform disorders, is felt to be primarily related to dopaminergic activity within the striatum. Physostigmine has been demonstrated to improve the abnormal movements in patients with tardive dyskinesia while scopolamine tends to aggravate abnormal movements and in some cases elicits abnormal movement not previously observed. This evidence supports the hypothesis that anticholinergic therapy in patients prone to develop tardive dyskinesia may increase the incidence of this disorder by lowering the threshold for the appearance of these movements.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D010830 Physostigmine A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. Eserine
D004491 Edrophonium A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles. Edrophonium Chloride,Edrophonium Bromide,Edroponium,Tensilon,Bromide, Edrophonium,Chloride, Edrophonium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001008 Anxiety Disorders Persistent and disabling ANXIETY. Anxiety Neuroses,Anxiety States, Neurotic,Neuroses, Anxiety,Anxiety Disorder,Anxiety State, Neurotic,Disorder, Anxiety,Disorders, Anxiety,Neurotic Anxiety State,Neurotic Anxiety States,State, Neurotic Anxiety,States, Neurotic Anxiety

Related Publications

H L Klawans, and R Rubovits
January 1985, Clinical neuropharmacology,
H L Klawans, and R Rubovits
February 1983, The American journal of psychiatry,
H L Klawans, and R Rubovits
December 1989, Journal of clinical psychopharmacology,
H L Klawans, and R Rubovits
January 1981, The American journal of psychiatry,
H L Klawans, and R Rubovits
June 1974, Psychopharmacologia,
H L Klawans, and R Rubovits
January 1983, Modern problems of pharmacopsychiatry,
H L Klawans, and R Rubovits
July 1977, The American journal of psychiatry,
H L Klawans, and R Rubovits
January 2000, The Cochrane database of systematic reviews,
H L Klawans, and R Rubovits
January 2018, The Cochrane database of systematic reviews,
H L Klawans, and R Rubovits
March 2000, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Copied contents to your clipboard!